IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS ANDTHERAPEUTIC ADVANCES (VITA): BIOENGINEEREDGRAFTS FOR PERIPHERAL VASCULAR DISEASE FOR BASEPERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014

Information

• Research Project
• 9201159

• ApplicationId

  9201159

• Core Project Number

  N01HV000000

• Full Project Number

  268201400011C-3-0-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  11/15/2013 - 11 years ago

• Project End Date

  11/14/2016 - 8 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2016

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• Humacyte, Inc.

The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.

IC Name

• Activity

  N01

• Administering IC

  HL

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  478270

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  837

• Ed Inst. Type

• Funding ICs

  NHLBI:478270\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  HUMACYTE, INC.

• Organization Department

• Organization DUNS

  557190449

• Organization City

  RESEARCH TRIANGLE PARK

• Organization State

  NC

• Organization Country

  UNITED STATES

• Organization Zip Code

  277092695

• Organization District

  UNITED STATES